The Latest Breaking News on Pharma

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first year

FDA clears Florida's plan to import cheaper prescription drugs from Canada, marking a seismic shift in U.S. drug pricing and a win for consumers.

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

Eli Lilly stock is Tuesday's IBD Stock Of The Day after the company wrapped its $1.4 billion takeover of Point Biopharma.

The pharmaceutical industry is expected to grow rapidly due to rising global medical needs and technological advancements. With the industry expected to thrive in the coming years, it could be wise to buy Zoetis (ZTS), AstraZeneca (AZN) and Taro Pharmaceutical (TARO) for steady returns. Read more.

The pharmaceutical industry’s robust outlook is driven by high healthcare spending globally, consistent R&D efforts, and the rapid adoption of advanced digital technologies. So, let’s analyze if investors should adopt a bullish or bearish stance on pharma stocks such as Tilray Brands (TLRY), CytomX Therapeutics (CTMX), and Wave Life Sciences…

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

CymaBay is sprinting to the finish line with a treatment for a serious liver disease and CBAY stock is on a massive run.

Hospitals rely on scores of generic drugs given by injection. But these workhorses are often in short supply. Cheap prices have led to factory closures that leave the supply chain vulnerable.